Trial intelligence / Profile preview

M01ZH09 typhoid vaccine challenge study with Ty21a positive control

2011-000381-35Phase 2Unknown

Sponsor
University of Oxford
Start
Aug 2011
Modality
Vaccines & Immunotherapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in typhoid fever comparing M01ZH09 vaccine, Vaccine placebo and Ty21a vaccine (3 arms). Primary endpoint: Relative protective effect of M01ZH09 versus placebo. Status: unknown.

02

Drugs

M01ZH09typhoid vaccine, live oral
03

Conditions

typhoid fever

Beyond the preview

Go deeper on 2011-000381-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000381-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call